2-((4-Oxo-3-(p-tolyl)-3,4,6,7-tetrahydrothieno[3,2-d]pyrimidin-2-yl)thio)-N-(2-(trifluoromethyl)phenyl)acetamide

Catalog No. :
ACBQDX824
CAS No. :
686771-29-9
Molecular Formula :
C22H18F3N3O2S2
Molecular Weight :
477.53

IUPAC Name:2-((4-oxo-3-(p-tolyl)-3,4,6,7-tetrahydrothieno[3,2-d]pyrimidin-2-yl)thio)-N-(2-(trifluoromethyl)phenyl)acetamide

2-((4-Oxo-3-(p-tolyl)-3,4,6,7-tetrahydrothieno[3,2-d]pyrimidin-2-yl)thio)-N-(2-(trifluoromethyl)phenyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((4-Oxo-3-(p-tolyl)-3,4,6,7-tetrahydrothieno[3,2-d]pyrimidin-2-yl)thio)-N-(2-(trifluoromethyl)phenyl)acetamide
IUPAC Name2-((4-oxo-3-(p-tolyl)-3,4,6,7-tetrahydrothieno[3,2-d]pyrimidin-2-yl)thio)-N-(2-(trifluoromethyl)phenyl)acetamide
Molecular FormulaC22H18F3N3O2S2
Molecular Weight477.53
SMILESO=C(NC1=CC=CC=C1C(F)(F)F)CSC2=NC(CCS3)=C3C(N2C4=CC=C(C)C=C4)=O
InChI KeyMMQCWAFDEWUSGP-UHFFFAOYSA-N
Synonym2-((4-oxo-3-(p-tolyl)-3,4,6,7-tetrahydrothieno[3,2-d]pyrimidin-2-yl)thio)-N-(2-(trifluoromethyl)phenyl)acetamide;Acetamide, 2-[[3,4,6,7-tetrahydro-3-(4-methylphenyl)-4-oxothieno[3,2-d]pyrimidin-2-yl]thio]-N-[2-(trifluoromethyl)phenyl]-
CAS No.686771-29-9

Synthetic Route by SureRoute

1. ACBQDX824 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBQDX824 route product structure diagram
    ACBQDX824686771-29-9
Inquiry

2. ACBQDX824 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBQDX824 route product structure diagram
    ACBQDX824686771-29-9
Inquiry

Comments (0)